| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Operating Officer | SVP, Chief Business Officer
1 company
Dahan Michel is a SVP, Chief Operating Officer at Akebia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $780K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,398 | $19.64 | $27,456.72 | -1.4% | |
| Sep 28, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 5,000 | $19.30 | $96,500.00 | -4.9% | |
| Aug 15, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 5,000 | $15.00 | $75,000.00 | -4.7% | |
| Jul 3, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,399 | $14.26 | $19,946.52 | -1.3% | |
| Apr 3, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,401 | $9.18 | $12,857.68 | -1.3% | |
| Jan 1, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,629 | $10.49 | $17,089.19 | -2.3% | |
| Oct 1, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,401 | $8.95 | $12,545.67 | -1.9% | |
| Jul 5, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,402 | $7.47 | $10,468.03 | -1.9% | |
| Apr 4, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Business Officer | Sell | 1,401 | $9.41 | $13,183.41 | -1.8% |